Document Detail


Genetics of pulmonary arterial hypertension.
MedLine Citation:
PMID:  19634078     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tremendous progress has been made in understanding the genetics of hereditable pulmonary arterial hypertension (HPAH) since its description in the 1950s. Germline mutations in the gene coding bone morphogenetic receptor type 2 ( BMPR2) are detectable in the majority of cases of HPAH, and in a small proportion of cases of idiopathic pulmonary arterial hypertension (IPAH). HPAH is an autosomal dominant disease characterized by reduced penetrance, variable expressivity, female predominance, and genetic anticipation. These characteristics suggest that endogenous and exogenous factors modify disease expression and areas of emphasis for future investigation. The variable clinical expression makes genetic counseling complex because the majority of carriers of a BMPR2 mutation will not be diagnosed with the disease. This issue will become increasingly important, as clinical testing for BMPR2 mutations is now available for the evaluation of patients and family members with HPAH and IPAH.
Authors:
Eric D Austin; James E Loyd; John A Phillips
Related Documents :
12503718 - Pathobiology of pulmonary arterial hypertension.
21132868 - Rethinking the prosaicism of mosaicism; is it in us?
19546528 - A synergistic association of ace i/d and enos g894t gene variants with the progression ...
9269698 - Angiotensin i converting enzyme gene polymorphism and diabetic nephropathy in type ii d...
17435238 - Associations between sperm competition and natural variation in male reproductive genes...
12190658 - Prevalence of endothelial nitric oxide synthase gene polymorphisms in patients with ato...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2009-07-24
Journal Detail:
Title:  Seminars in respiratory and critical care medicine     Volume:  30     ISSN:  1098-9048     ISO Abbreviation:  Semin Respir Crit Care Med     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-07-27     Completed Date:  2009-10-12     Revised Date:  2012-06-25    
Medline Journal Info:
Nlm Unique ID:  9431858     Medline TA:  Semin Respir Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  386-98     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Division of Pulmonary, Allergy, and Immunology Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2578, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Morphogenetic Protein Receptors, Type II / genetics*
Female
Genetic Counseling
Genetic Predisposition to Disease
Genetic Testing / methods
Germ-Line Mutation
Humans
Hypertension, Pulmonary / genetics*
Male
Sex Factors
Grant Support
ID/Acronym/Agency:
K12 RR1 7697/RR/NCRR NIH HHS; P01 HL072058/HL/NHLBI NIH HHS; RR000095/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
EC 2.7.11.30/BMPR2 protein, human; EC 2.7.11.30/Bone Morphogenetic Protein Receptors, Type II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathology of pulmonary arterial hypertension.
Next Document:  Diagnosis and hemodynamic assessment of pulmonary arterial hypertension.